“…Most pharmacological interventions for neglect have centered on the use of dopaminergic and noradrenergic agents. Dopaminergic treatments such as bromocriptine (Barrett, Crucian, Schwartz, et al, 1999;Grujic et al, 1998;Hurford, Stringer, & Jann, 1998;Fleet, Valenstein, Watson, & Heilman, 1987), apomorphine (Geminiani, Bottini, & Sterzi, 1998), carbidopa/levodopa (Mukand et al, 2001), and amantadine (Buxbaum, Ferraro, Whyte, Gershkoff, & Coslett, in press) are based on the observation that unilateral dopaminergic ablation in animals produces a syndrome comparable to human neglect (Schwarting & Huston, 1996). Noradrenergic treatments are based on observed abnormal arousal in neglect and reported benefit of stimulants in motor and language rehabilitation (e.g., Walker-Batson, Curtis, et al, 2001;e.g., Walker-Batson, Smith, Curtis, Unwin, & Greenlee, 1995).…”